Osteoporosis With Current Fragility Fracture | Partnership for Applied Research in Fracture Prevention Programs for the Elderly

Osteoporosis With Current Fragility Fracture research study

What is the primary objective of this study?

During their lifetime, approximately 50% of Canadian women and 30% of Canadian men will experience at least one fracture due to bone fragility (FF). Evidence is growing regarding prevention programs' effectiveness to prevent falls, but prevention of fractures through fall prevention programs has enjoyed limited success. Falls prevention programs and post-fracture screening programs leading to pharmacological treatment are very different strategies, with a shared ultimate goal. Coordination between those who repair fractures and those who manage the patient to prevent the next fracture is critical. The overarching aim of this proposal is to generate evidence-based knowledge about the effectiveness and cost-effectiveness of an integrated FF prevention program, as well as a portrait of the barriers and facilitating factors for such programs. More specifically, the objectives are: 1) to combine existing fall prevention and post-fracture management programs in the province of Quebec into integrated FF prevention programs; 2) to compare the performance of these integrated programs to control sites, using a pragmatic study design; 3) to identify barriers as well as factors that improve effectiveness across different implementation milieu; and 4) to develop and engage in active knowledge transfer activities in Quebec regions where integrated FF prevention programs are neither adequately nor successfully implemented. Drawing upon the literature on integrated healthcare, fall and fracture prevention, we hypothesize that an integrated FF program can reduce the risk of a subsequent fracture by at least 30% in the population of interest. The proposed team is poised to develop new interdisciplinary collaborations among healthcare practitioners and decision makers involved in the prevention of FFs. The program is built upon existing healthcare and structures and programs and in turn, will truly measure the effectiveness of an integrated FF prevention program. The results will ultimately lead to improvements in the existing knowledge base, address policy-relevant and health systems problems, and assist in the design and implementation of FFs prevention programs.

Who is eligible to participate?

Inclusion Criteria: - 50 years of age and over - must have a primary care physician - must be able to follow simple instructions - must have sustained a fragility fracture within three months of the recruitment date. Exclusion Criteria: - severe kidney insufficiency (grade 4 or 5) - advanced stage of cancer - fracture to sites not commonly associated with osteoporosis such as toe, finger, hand, foot, ankle, patella, head, and cervical spine.

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Osteoporosis With Current Fragility Fracture

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:Integrated programEach participant's primary care physician will receive written information containing a presumed osteoporosis diagnosis, investigations to be performed, correct interpretation of any bone densitometry results in the context of a fragility fracture, and treatment options. The study coordinator will be responsible for orienting the participant to an appropriate local fall prevention program.

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Control group

Integrated programParticipants will be involved in an integrated interorganisational fragility fracture prevention program, which combines both post-fracture management as well as fall prevention strategies. The intervention will last up to 18 months.

Study Status

Active, not recruiting

Start Date: January 2013

Completed Date: June 2019

Phase: N/A

Type: Interventional


Primary Outcome: Incidence of secondary fragility fracture

Secondary Outcome: Initiation of osteoporosis treatment by the primary care physician

Study sponsors, principal investigator, and references

Principal Investigator: Isabelle Gaboury, PhD

Lead Sponsor: Université de Sherbrooke

Collaborator: Canadian Institutes of Health Research (CIHR)

More information:

Discuss Fracture